| Approaches to catheter ablation for persistent atrial fibrillation A Verma, C Jiang, TR Betts, J Chen, I Deisenhofer, R Mantovan, L Macle, ... New England Journal of Medicine 372 (19), 1812-1822, 2015 | 2127 | 2015 |
| Cardiac-resynchronization therapy for mild-to-moderate heart failure ASL Tang, GA Wells, M Talajic, MO Arnold, R Sheldon, S Connolly, ... New England Journal of Medicine 363 (25), 2385-2395, 2010 | 2127 | 2010 |
| Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial CA Morillo, A Verma, SJ Connolly, KH Kuck, GM Nair, J Champagne, ... Jama 311 (7), 692-699, 2014 | 719 | 2014 |
| Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs JL Sapp, GA Wells, R Parkash, WG Stevenson, L Blier, JF Sarrazin, ... New England Journal of Medicine 375 (2), 111-121, 2016 | 711 | 2016 |
| Pacemaker or defibrillator surgery without interruption of anticoagulation DH Birnie, JS Healey, GA Wells, A Verma, AS Tang, AD Krahn, ... New England Journal of Medicine 368 (22), 2084-2093, 2013 | 662 | 2013 |
| Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control AC Skanes, JS Healey, JA Cairns, P Dorian, AM Gillis, MS McMurtry, ... Canadian Journal of Cardiology 28 (2), 125-136, 2012 | 636 | 2012 |
| Cryoablation or drug therapy for initial treatment of atrial fibrillation JG Andrade, GA Wells, MW Deyell, M Bennett, V Essebag, J Champagne, ... New England Journal of Medicine 384 (4), 305-315, 2021 | 548 | 2021 |
| 2014 focused update of the Canadian Cardiovascular Society Guidelines for the management of atrial fibrillation A Verma, JA Cairns, LB Mitchell, L Macle, IG Stiell, D Gladstone, ... Canadian Journal of Cardiology 30 (10), 1114-1130, 2014 | 501 | 2014 |
| The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society comprehensive guidelines for the management of atrial fibrillation JG Andrade, M Aguilar, C Atzema, A Bell, JA Cairns, CC Cheung, JL Cox, ... Canadian Journal of Cardiology 36 (12), 1847-1948, 2020 | 445 | 2020 |
| Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter JA Cairns, S Connolly, S McMurtry, M Stephenson, M Talajic, ... Canadian Journal of Cardiology 27 (1), 74-90, 2011 | 391 | 2011 |
| Warfarin use and the risk for stroke and bleeding in patients with atrial fibrillation undergoing dialysis M Shah, M Avgil Tsadok, CA Jackevicius, V Essebag, MJ Eisenberg, ... Circulation 129 (11), 1196-1203, 2014 | 389 | 2014 |
| Detection of pulmonary vein and left atrial scar after catheter ablation with three-dimensional navigator-gated delayed enhancement MR imaging: initial experience DC Peters, JV Wylie, TH Hauser, KV Kissinger, RM Botnar, V Essebag, ... Radiology 243 (3), 690-695, 2007 | 387 | 2007 |
| Discerning the incidence of symptomatic and asymptomatic episodes of atrial fibrillation before and after catheter ablation (DISCERN AF): a prospective, multicenter study A Verma, J Champagne, J Sapp, V Essebag, P Novak, A Skanes, ... JAMA internal medicine 173 (2), 149-156, 2013 | 340 | 2013 |
| 2016 focused update of the Canadian Cardiovascular Society guidelines for the management of atrial fibrillation L Macle, J Cairns, K Leblanc, T Tsang, A Skanes, JL Cox, JS Healey, ... Canadian Journal of Cardiology 32 (10), 1170-1185, 2016 | 337 | 2016 |
| Frequency and causes of implantable cardioverter-defibrillator therapies: is device therapy proarrhythmic? JJ Germano, M Reynolds, V Essebag, ME Josephson The American journal of cardiology 97 (8), 1255-1261, 2006 | 278 | 2006 |
| 2018 focused update of the Canadian Cardiovascular Society guidelines for the management of atrial fibrillation JG Andrade, A Verma, LB Mitchell, R Parkash, K Leblanc, C Atzema, ... Canadian Journal of Cardiology 34 (11), 1371-1392, 2018 | 258 | 2018 |
| Influence of age, sex, and atrial fibrillation recurrence on quality of life outcomes in a population of patients with new-onset atrial fibrillation: the Fibrillation Registry … MR Reynolds, T Lavelle, V Essebag, DJ Cohen, P Zimetbaum American heart journal 152 (6), 1097-1103, 2006 | 245 | 2006 |
| Comparison of nested case-control and survival analysis methodologies for analysis of time-dependent exposure V Essebag, RW Platt, M Abrahamowicz, L Pilote BMC medical research methodology 5, 1-6, 2005 | 235 | 2005 |
| Adenosine-guided pulmonary vein isolation for the treatment of paroxysmal atrial fibrillation: an international, multicentre, randomised superiority trial L Macle, P Khairy, R Weerasooriya, P Novak, A Verma, S Willems, ... The Lancet 386 (9994), 672-679, 2015 | 223 | 2015 |
| Comparative effectiveness of rhythm control vs rate control drug treatment effect on mortality in patients with atrial fibrillation R Ionescu-Ittu, M Abrahamowicz, CA Jackevicius, V Essebag, ... Archives of Internal Medicine 172 (13), 997-1004, 2012 | 203 | 2012 |
Jeff HealeyProfessor of Medicine, McMaster UniversityDirección de correo verificada de phri.ca
